Table 5 Data collection schedule
Outcomes | Variables | BL1 | BL2 | 2W | 6W | 12W | 24W | 39W | 52W |
|---|---|---|---|---|---|---|---|---|---|
Background | Demographics; comorbidities | Q | |||||||
Duration of episode; history of SMT and massage care | Q | ||||||||
Primary Objective | Dose-Response | ||||||||
Headache | CGH frequency in 4 weeks prior | Q | D, Q | D, Q | D, Q | D, Q | D, Q | D, Q | |
CGH pain | Q | D, Q | D, Q | D, Q | D, Q | D, Q | D, Q | ||
CGH disability | Q | Q | Q | Q | Q | Q | |||
CGH improvement: pain, global perceived effect | Q | Q | Q | Q | Q | ||||
Other headache days | D, Q | D, Q | D, Q | D, Q | D, Q | D, Q | |||
Neck Pain | Frequency (days) of neck pain | Q | Q | Q | Q | Q | Q | Q | |
Quality of Life | EuroQol-5D | Q | Q | Q | Q | Q | |||
Satisfaction | Likert Scale, success of care | Q | Q | Q | Q | Q | |||
Medication | Frequency of prescription and non-prescription medication (days) | D, Q | D, Q | D, Q | D, Q | D, Q | D, Q | ||
Outside Care | CGH care from external providers | Q | Q | Q | Q | Q | Q | Q | |
Objective Measures | Kinematics and cervical segmental joint function | X | X | ||||||
Secondary Objective | Cost Effectiveness | ||||||||
Healthcare Utilization and lost productivity | Q | Q | Q | Q | Q | Q | |||
Utilities | Quality-adjusted life years EuroQol-5D | Q | Q | Q | Q | Q | |||
Outcomes | CGH frequency (days) and intensity (in last 4 wks) | Q | D, Q | D | D | D | D | D | |
Tertiary Objective | Effects of Expectations | ||||||||
Quantitative | Confidence in treatment success | Q | Q | Q | Q | Q | Q | Q | |
Perceptions of the Patient-provider encounter | Q | Q | |||||||
Qualitative | Meaning, constructs of expectations | I | |||||||